125 related articles for article (PubMed ID: 38031995)
21. The burden of HBV infection in HCV patients in Italy and the risk of reactivation under DAA therapy.
Stroffolini T; Sagnelli E; Sagnelli C; Smedile A; Furlan C; Morisco F; Coppola N; Andriulli A; Almasio PL
Dig Liver Dis; 2019 Mar; 51(3):434-437. PubMed ID: 30361062
[TBL] [Abstract][Full Text] [Related]
22. Direct-acting antivirals for chronic hepatitis C.
Jakobsen JC; Nielsen EE; Feinberg J; Katakam KK; Fobian K; Hauser G; Poropat G; Djurisic S; Weiss KH; Bjelakovic M; Bjelakovic G; Klingenberg SL; Liu JP; Nikolova D; Koretz RL; Gluud C
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD012143. PubMed ID: 28922704
[TBL] [Abstract][Full Text] [Related]
23. The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four european countries.
Mennini FS; Marcellusi A; Robbins Scott S; Montilla S; Craxi A; Buti M; Gheorghe L; Ryder S; Kondili LA
Liver Int; 2021 May; 41(5):934-948. PubMed ID: 33529499
[TBL] [Abstract][Full Text] [Related]
24. The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies.
Duberg AS; Blach S; Falconer K; Kåberg M; Razavi H; Aleman S
Scand J Gastroenterol; 2015 Feb; 50(2):233-44. PubMed ID: 25515032
[TBL] [Abstract][Full Text] [Related]
25. Impact of direct-acting antivirals for HCV on mortality in a large population-based cohort study.
Janjua NZ; Wong S; Abdia Y; Jeong D; Buller-Taylor T; Adu PA; Samji H; Wilton J; Pearce M; Butt ZA; Yu A; Binka M; Bartlett S; Alvarez M; Krajden M
J Hepatol; 2021 Nov; 75(5):1049-1057. PubMed ID: 34097994
[TBL] [Abstract][Full Text] [Related]
26. Asthma-related mortality in the United States, 1999 to 2015: A multiple causes of death analysis.
Kodadhala V; Obi J; Wessly P; Mehari A; Gillum RF
Ann Allergy Asthma Immunol; 2018 Jun; 120(6):614-619. PubMed ID: 29548908
[TBL] [Abstract][Full Text] [Related]
27. Sustained virologic response to direct-acting antiviral agents predicts better outcomes in hepatitis C virus-infected patients: A retrospective study.
Colussi G; Donnini D; Brizzi RF; Maier S; Valenti L; Catena C; Cavarape A; Sechi LA; Soardo G
World J Gastroenterol; 2019 Oct; 25(40):6094-6106. PubMed ID: 31686765
[TBL] [Abstract][Full Text] [Related]
28. Changes in liver-related mortality by etiology and sequelae: underlying versus multiple causes of death.
Sheu MJ; Liang FW; Lin CY; Lu TH
Popul Health Metr; 2021 Apr; 19(1):22. PubMed ID: 33926463
[TBL] [Abstract][Full Text] [Related]
29. The impact of estimation methods for alcohol-attributable mortality on long-term trends for the general population and by educational level in Finland and Italy (Turin).
Van Hemelrijck WMJ; Martikainen P; Zengarini N; Costa G; Janssen F
PLoS One; 2023; 18(12):e0295760. PubMed ID: 38096271
[TBL] [Abstract][Full Text] [Related]
30. Characteristics and Treatment Rate of Patients With Hepatitis C Virus Infection in the Direct-Acting Antiviral Era and During the COVID-19 Pandemic in the United States.
Nguyen VH; Kam L; Yeo YH; Huang DQ; Henry L; Cheung R; Nguyen MH
JAMA Netw Open; 2022 Dec; 5(12):e2245424. PubMed ID: 36477481
[TBL] [Abstract][Full Text] [Related]
31. Different approaches to the analysis of causes of death during the COVID-19 epidemic.
Fedeli U; Schievano E; Avossa F; Pitter G; Barbiellini Amidei C; Grande E; Grippo F
Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3610-3613. PubMed ID: 34002836
[TBL] [Abstract][Full Text] [Related]
32. Mortality among persons in care with hepatitis C virus infection: the Chronic Hepatitis Cohort Study (CHeCS), 2006-2010.
Mahajan R; Xing J; Liu SJ; Ly KN; Moorman AC; Rupp L; Xu F; Holmberg SD;
Clin Infect Dis; 2014 Apr; 58(8):1055-61. PubMed ID: 24523214
[TBL] [Abstract][Full Text] [Related]
33. Treatment of HCV reduces viral hepatitis-associated liver-related mortality in patients: An ERCHIVES study.
Butt AA; Yan P; Shaikh OS; Lo Re V; Abou-Samra AB; Sherman KE
J Hepatol; 2020 Aug; 73(2):277-284. PubMed ID: 32145260
[TBL] [Abstract][Full Text] [Related]
34. Improved liver transplant waitlist mortality and lower risk of disease progression among chronic hepatitis C patients awaiting liver transplantation after the introduction of direct-acting antiviral therapies in the United States.
Young K; Liu B; Bhuket T; Gish RG; Wong RJ
J Viral Hepat; 2019 Mar; 26(3):350-361. PubMed ID: 30412318
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C Virus Infection and the Temporal Trends in the Risk of Liver Cancer: A National Register-Based Cohort Study in Sweden.
Batyrbekova N; Aleman S; Lybeck C; Montgomery S; Duberg AS
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):63-70. PubMed ID: 31719064
[TBL] [Abstract][Full Text] [Related]
36. COPD-Related Mortality before and after Mass COVID-19 Vaccination in Northern Italy.
Fedeli U; Casotto V; Barbiellini Amidei C; Vianello A; Guarnieri G
Vaccines (Basel); 2023 Aug; 11(8):. PubMed ID: 37631960
[TBL] [Abstract][Full Text] [Related]
37. Direct-acting antivirals for chronic hepatitis C.
Jakobsen JC; Nielsen EE; Feinberg J; Katakam KK; Fobian K; Hauser G; Poropat G; Djurisic S; Weiss KH; Bjelakovic M; Bjelakovic G; Klingenberg SL; Liu JP; Nikolova D; Koretz RL; Gluud C
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD012143. PubMed ID: 28585310
[TBL] [Abstract][Full Text] [Related]
38. Favorable impact in hepatitis C-related mortality following free access to direct-acting antivirals in Spain.
Politi J; Guerras JM; Donat M; Belza MJ; Ronda E; Barrio G; Regidor E
Hepatology; 2022 May; 75(5):1247-1256. PubMed ID: 34773281
[TBL] [Abstract][Full Text] [Related]
39. Viral eradication reduces all-cause mortality in patients with chronic hepatitis C virus infection: a propensity score analysis.
Tada T; Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Yama T; Tanaka J
Liver Int; 2016 Jun; 36(6):817-26. PubMed ID: 26787002
[TBL] [Abstract][Full Text] [Related]
40. Free Access to Direct-Acting Antivirals in Spain: More Favorable Impact on Hepatitis C Mortality Among Highly Educated People.
Politi J; Regidor E; Donat M; Pulido J; Guerras JM; Barrio G; Belza MJ
Clin Infect Dis; 2023 Apr; 76(8):1423-1430. PubMed ID: 36471910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
